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Summary
The Wee1 kinase phosphorylates and inhibits cyclin-
dependent kinase 1 (Cdk1), thereby delaying entry
into mitosis until appropriate conditions have been
met. An understanding of the mechanisms that regu-
late Wee1 should provide new insight into how cells
make the decision to enter mitosis. We report here
that Swe1, the budding-yeast homolog of Wee1, is di-
rectly regulated by Cdk1. Phosphorylation of Swe1 by
Cdk1 activates Swe1 and is required for formation of
a stable Swe1-Cdk1 complex that maintains Cdk1 in
the inhibited state. Dephosphorylation of Cdk1 leads
to further phosphorylation of Swe1 and release of
Cdk1. Thus, Cdk1 both positively and negatively reg-
ulates its own inhibitor. Regulation of the Swe1-Cdk1
complex is likely to play a critical role in controlling
the transition into mitosis.
Introduction
Entry into mitosis is initiated by synthesis of mitotic
cyclins, which bind and activate cyclin-dependent ki-
nase 1 (Cdk1). Activation of Cdk1 at the G2/M transition
is tightly regulated by the Wee1 kinase and the Cdc25
phosphatase. Wee1 phosphorylates and inhibits Cdk1,
thereby delaying entry into mitosis, while Cdc25 re-
moves the inhibitory phosphorylation and promotes en-
try into mitosis (Dunphy and Kumagai, 1991; Feather-
stone and Russell, 1991; Gautier et al., 1991; Gould and
Nurse, 1989; Kumagai and Dunphy, 1991; Lundgren et
al., 1991; Russell and Nurse, 1986, 1987; Strausfeld et
al., 1991). Both Wee1 and Cdc25 have been highly con-
served, suggesting that similar mechanisms control en-
try into mitosis in all eukaryotic cells. In fission yeast
and budding yeast, Wee1 is thought to delay entry into
mitosis until a critical cell size has been reached (Kel-
logg, 2003; Nurse, 1975; Rupes, 2002).
The molecular mechanisms that regulate Wee1 are
poorly understood. Xenopus Wee1 undergoes extens-
ive hyperphosphorylation upon entry into mitosis
(Mueller et al., 1995; Tang et al., 1993). Hyperphosphor-
ylation of Wee1 is dependent upon mitotic Cdk1 activ-
ity in crude extracts, and purified mitotic Cdk1 can di-
rectly phosphorylate Wee1 in vitro. In addition, the
hyperphosphorylated form of Wee1 isolated from mi-*Correspondence: kellogg@darwin.ucsc.edutotic extracts has reduced kinase activity (Mueller et al.,
1995; Tang et al., 1993). Taken together, these observa-
tions have led to the idea of a positive feedback loop
in which Cdk1 directly hyperphosphorylates and inacti-
vates Wee1, thereby contributing to a rapid rise in Cdk1
activity and entry into mitosis. However, it has remained
unclear how the loop is initially triggered or how Cdk1
can phosphorylate Wee1 since Wee1 inhibits Cdk1. In
addition, Wee1 undergoes hyperphosphorylation in ex-
tracts that appear to lack mitotic Cdk1 activity, sug-
gesting that there is at least one other kinase that can
directly phosphorylate Wee1 (Mueller et al., 1995).
Nim1-related kinases phosphorylate the C terminus of
Wee1 in vitro, resulting in reduced kinase activity; how-
ever, the in vivo relevance of this phosphorylation has
not been clearly established (Coleman et al., 1993).
A more detailed knowledge of the mechanisms that
regulate Wee1 will be an important step toward under-
standing how cells make the decision to enter mitosis.
We therefore initiated experiments aimed at under-
standing how Swe1, the budding-yeast homolog of
Wee1, is regulated. Swe1 phosphorylates and inhibits
Cdc28, the budding-yeast homolog of Cdk1. The pri-
mary mitotic cyclin that binds and activates Cdc28 to
promote entry into mitosis is Clb2 (Fitch et al., 1992;
Nasmyth, 1993; Richardson et al., 1992). We report here
that the Clb2/Cdc28 complex plays intricate and unex-
pected roles in the regulation of Swe1.
Results
Swe1 Undergoes Highly Dynamic Cdc28-Dependent
Phosphorylation during Mitosis
The Swe1 protein first appears during late G1 and then
undergoes dramatic hyperphosphorylation as cells en-
ter mitosis (Harvey and Kellogg, 2003; Sreenivasan and
Kellogg, 1999). Swe1 hyperphosphorylation is exactly
correlated with levels of the mitotic cyclin Clb2, which
suggests that hyperphosphorylation is induced by the
activity of Clb2/Cdc28 complexes. To test this possi-
bility, we utilized an analog-sensitive version of Cdc28
(Cdc28-as) that can be rapidly and specifically inhibited
in vivo by addition of the adenine analog 1NM-PP1
(Bishop et al., 2000). Cells carrying Cdc28-as were ar-
rested in mitosis by expression of a nondegradable ver-
sion of Clb2, which resulted in hyperphosphorylation of
Swe1. We then added 1NM-PP1 to the cells and fol-
lowed the behavior of Swe1 by Western blotting (Figure
1A). Swe1 hyperphosphorylation was significantly re-
duced within one minute of inhibiting Cdc28-as activity
and was almost completely eliminated within 5 min.
Treatment of wild-type cells with 1NM-PP1 had no ef-
fect on Swe1 hyperphosphorylation (Figure 1B). To en-
sure that the behavior of Swe1 was not an artifact
caused by overexpression of Clb2, we carried out the
same experiment in cells undergoing a normal cell cy-
cle. Cells were released from a G1 arrest, and 1NM-PP1
was added when the cells entered mitosis at 90 min
(Figure 1C). Again, we observed that inhibition of
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408Figure 1. Phosphorylation of Swe1 by Clb2/Cdc28
(A) Cells carrying the cdc28-as allele were arrested in late mitosis by expression of a version of Clb2 lacking the destruction box. Cdc28-as
was then inhibited by addition of 1NM-PP1, and the phosphorylation state of Swe1 was assayed by Western blotting. The lane labeled “Mock
Treated” is taken from cells treated with DMSO for 5 min.
(B) Wild-type cells were arrested in late mitosis and treated with 1NM-PP1 for 5 min as described for Figure 1A.
(C) 1NM-PP1 was added to cdc28-as cells 90 min after release from a G1 arrest, and Swe1 hyperphosphorylation was assayed by Western
blotting. The lane labeled “Mitosis” shows a sample taken just before addition of 1NM-PP1, and the lane labeled “Mock Treated” was treated
with DMSO for 10 min.
(D) A Coomassie-blue-stained polyacrylamide gel showing purified Swe1-3×HA and Clb2-3×HA/Cdc28. The arrowheads indicate chaperone
proteins that copurify with the 3×HA-tagged proteins, and the asterisk marks IgG heavy chain.
(E) The indicated combinations of proteins were incubated in the presence or absence of ATP and 1NM-PP1, and the phosphorylation state
of Swe1 was assayed by Western blotting.Cdc28-as caused rapid loss of Swe1 hyperphosphory- c
plation. We conclude that Swe1 hyperphosphorylation is
dependent upon Cdc28 activity in vivo. In addition, p
eSwe1 hyperphosphorylation is highly dynamic and re-
quires continuous signaling from Cdc28. d
t
SClb2/Cdc28 Binds and Phosphorylates Swe1
To test whether Swe1 is a direct substrate of Clb2/ c
cCdc28 complexes, we utilized proteins purified from
yeast by immunoaffinity chromatography. Briefly, we s
sexpressed 3×HA-tagged versions of Swe1 and Clb2
and bound the tagged proteins to anti-HA beads. After C
washing with buffer, the proteins were eluted with an
excess of an HA dipeptide. The purifications were car- o
tried out in the presence of 1.0 M KCl to remove weakly
associating proteins. The purified proteins are shown in a
bFigure 1D. Immunoglobulin heavy chain and copurifying
chaperone proteins are marked with an asterisk and ar- u
trows, respectively. Analysis of the Clb2/Cdc28 com-
plexes by mass spectrometry indicated that the Cks1 2
tprotein is also present, as expected from previous
work; however, Cks1 is of low molecular weight and cannot be seen on this gel (Hadwiger et al., 1989). The
urified Clb2/Cdc28 was able to induce quantitative hy-
erphosphorylation of Swe1, as indicated by a shift in
lectrophoretic mobility (Figure 1E). The shift is depen-
ent upon the presence of ATP, indicating that it is due
o phosphorylation. To ensure that phosphorylation of
we1 is not due to a contaminating kinase activity, we
arried out the same reactions using Clb2/Cdc28-as
omplexes. Addition of 1NM-PP1 to these reactions
trongly inhibited hyperphosphorylation of Swe1, con-
istent with the idea that Swe1 is a direct substrate of
lb2/Cdc28 complexes (Figure 1E).
To provide further support for direct phosphorylation
f Swe1 by Clb2/Cdc28, we tested whether these pro-
eins associate with each other. Purified Swe1 was
dded to Clb2/Cdc28 complexes bound to beads. The
eads were then washed, and Western blotting was
sed to test for Swe1 binding. Swe1 bound to beads
hat carry Clb2/Cdc28 but not to control beads (Figure
A, compare lanes 1 and 5). The same result was ob-
ained when we used a version of Cdc28 in which the
onserved tyrosine phosphorylated by Swe1 was changed
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409Figure 2. Phosphorylation of Clb2/Cdc28 by Swe1 Restricts the Ability of Clb2/Cdc28 to Phosphorylate Swe1
(A) Extracts made from wild-type cells or cells carrying Cdc28-Y19F were arrested in mitosis with benomyl, and Clb2/Cdc28 complexes were
immunoprecipitated in the presence of 1 M KCl using affinity-purified anti-Clb2 polyclonal antibody. Control precipitations were carried out
using an affinity-purified polyclonal antibody raised against maltose binding protein. Purified Swe1 was added to the precipitated Clb2/Cdc28
complexes, and after allowing time for binding, the unbound Swe1 was washed away. The immunoprecipitates were then divided in half, ATP
was added to one half, and Swe1 hyperphosphorylation was assayed by Western blotting.
(B) The indicated combinations of purified proteins were incubated in the presence of [γ-32P]ATP, and phosphorylation events were assayed
by autoradiography after SDS-PAGE. An anti-Cdc28 Western blot of the purified Clb2/Cdc28 complexes shows that equal amounts of Clb2/
Cdc28 and Clb2/Cdc28-Y19F were added to the reactions.
(C) Purified wild-type Swe1 or Swe1-N584A was incubated in the presence of wild-type Clb2/Cdc28 under the same conditions as (B).
(D) The fully hyperphosphorylated form of Swe1 is unstable in crude extracts. The fully hyperphosphorylated form of 3×HA-Swe1 was gener-
ated in vitro and then mixed with sample buffer containing phosphatase inhibitors. Half of the sample was used to prepare a cell lysate under
the standard conditions that we used for Western blotting, while the other half was used as a control. 3×HA-Swe1 was detected with an anti-
HA antibody.to a phenylalanine (Cdc28-Y19F) (Figure 2A, compare
lanes 3 and 7). A systematic analysis of protein com-
plexes in budding yeast also identified an interaction
between Swe1 and Clb2 (Ho et al., 2002).
Phosphorylation of Cdc28 by Swe1 Inhibits
Phosphorylation of Swe1 by Cdc28
The finding that Clb2/Cdc28 can phosphorylate Swe1
is somewhat puzzling since previous work found thatWee1-related kinases phosphorylate and inhibit mitotic
Cdks (Booher et al., 1993; McGowan and Russell, 1993;
Mueller et al., 1995; Parker et al., 1992; Parker and Piw-
nica-Worms, 1992). One possible explanation is that
there was a large excess of Clb2/Cdc28 in the reactions
shown in Figure 1E, and Swe1 was therefore not able
to fully inhibit the excess Clb2/Cdc28. We tested this
possibility by determining whether Clb2/Cdc28 can
phosphorylate Swe1 in preformed Swe1-Clb2/Cdc28
Cell
410complexes. Purified Swe1 and Clb2/Cdc28 were used m
ato form complexes on beads, and excess protein was
washed away, as described for Figure 2A. We then s
tadded ATP to the preformed complexes and used
Western blotting to assay Swe1 hyperphosphorylation. e
cAddition of ATP to Swe1-Clb2/Cdc28 complexes led to
quantitative hyperphosphorylation of Swe1 (Figure 2A, b
hcompare lanes 1 and 2). Surprisingly, when the same
experiment was carried out using Clb2/Cdc28-Y19F a
tcomplexes, Swe1 was hyperphosphorylated to a much
greater extent (Figure 2A, compare lanes 2 and 4). b
mWestern blotting controls showed that there were equal
amounts of Cdc28 and Cdc28-Y19F in the reactions n
d(Figure 2A). Hereafter, we will refer to the phosphoryla-
tion of Swe1 by Cdc28 as “partial hyperphosphoryla- c
ftion” and the phosphorylation of Swe1 by dephosphor-
ylated Cdc28 as “full hyperphosphorylation.” a
bSimilar results were obtained when reactions were
carried out in solution. Purified Clb2/Cdc28 complexes o
fwere mixed with purified Swe1, and phosphorylation
events were monitored by incorporation of 32P (Figure c
2B). In these experiments, we observed phosphoryla-
tion of a group of bands near 65 kDa when Clb2/Cdc28 A
or Clb2/Cdc28-Y19F complexes were incubated alone t
with ATP (Figure 2B, lanes 1 and 2). Immunoprecipita- T
tion experiments confirmed that these bands corre- p
spond to Clb2 (data not shown). Addition of Swe1 to s
the reaction caused strong inhibition of Clb2 phosphor- o
ylation; however, Cdc28 was still able to partially hyper- t
phosphorylate Swe1, and Swe1 phosphorylated Cdc28 p
(Figure 2B, compare lanes 1 and 4). When Swe1 was a
added to Clb2/Cdc28-Y19F complexes, it was no t
longer able to phosphorylate Cdc28 or inhibit phos- Y
phorylation of Clb2. However, Swe1 was fully hyper- n
phosphorylated (Figure 2B, compare lanes 4 and 5). p
Note that this experiment used a higher-percentage l
polyacrylamide gel to allow resolution of Cdc28. As a
result, the Swe1 electrophoretic mobility shift is less i
hdramatic. Western blotting controls demonstrated that
there were equal amounts of Cdc28 and Cdc28-Y19F h
hin the reactions (Figure 2B).
These experiments suggested that phosphorylation p
lof Swe1 in vitro is due entirely to Clb2/Cdc28 activity.
However, it remained possible that part of the Clb2/ i
pCdc28-induced phosphorylation of Swe1 was due to
Swe1 autophosphorylation. For example, initial phos- p
ephorylation of Swe1 by Clb2/Cdc28 could activate
Swe1 to undergo extensive autophosphorylation. To t
ptest this possibility, we constructed and purified a cata-
lytically inactive version of Swe1 in which we changed t
na conserved asparagine in the catalytic domain to an
alanine (Swe1-N584A) (see Figure S1 in the Supplemen- p
ptal Data available with this article online). When purified
Swe1-N584A was incubated in the presence of Clb2/ l
7Cdc28 and [γ-32P]ATP, it failed to phosphorylate Cdc28
or inhibit phosphorylation of Clb2 but was fully hyper- C
qphosphorylated relative to wild-type Swe1 (Figure 2C).
These experiments demonstrated that Swe1 autophos- c
sphorylation does not contribute significantly to Swe1
hyperphosphorylation under these conditions. e
aWe noted that Clb2/Cdc28-Y19F appeared to fully
hyperphosphorylate purified Swe1 in vitro to a greater c
lextent than Swe1 is hyperphosphorylated in vivo, as
determined by direct comparison of the electrophoretic pobility of the in vitro phosphorylated form of Swe1
nd the most hyperphosphorylated form of Swe1 ob-
erved during mitosis in vivo (data not shown). A poten-
ial explanation for this observation is that the fully hyp-
rphosphorylated form of Swe1 is unstable under the
onditions used to make crude extracts for Western
lots. To test this possibility, we generated the fully
yperphosphorylated form of 3×HA-Swe1 in vitro and
dded it to the SDS-PAGE sample buffer that we used
o make cell extracts for Western blots. The sample
uffer with the added 3×HA-Swe1 was then used to
ake a crude cell extract under the conditions that we
ormally use to detect Swe1 hyperphosphorylation
uring the cell cycle. Western blotting revealed that the
rude extract caused the fully hyperphosphorylated
orm of Swe1 to completely disappear (Figure 2D). As
result, the added Swe1 migrated at a level compara-
le to the partially hyperphosphorylated form of Swe1
bserved in vivo. Thus, the fully hyperphosphorylated
orm of Swe1 is unstable in crude yeast extracts, which
ould explain why this form is not observed in vivo.
Mutant Version of Swe1 that Fails
o Undergo Hyperphosphorylation
o understand the in vivo functions of Swe1 hyperphos-
horylation, we used mass spectrometry to map the
ites on Swe1 that are phosphorylated by Clb2/Cdc28
r Clb2/Cdc28-Y19F in vitro. We identified 19 serine or
hreonine residues clustered at the N terminus that are
hosphorylated by Clb2/Cdc28 (Table 1, Figures 3A
nd 3B). Surprisingly, only 8 of the 19 sites resemble
he Cdc28 core consensus site (S/TP). Clb2/Cdc28-
19F phosphorylated an additional 14 serines or threo-
ines not followed by a proline. We also detected two
hosphorylated tyrosines (Y187 and Y357) that are
ikely due to Swe1 autophosphorylation.
To confirm that these sites are also phosphorylated
n vivo, we mapped phosphorylation sites on partially
yperphosphorylated Swe1 purified from cells. Since it
as not yet been possible to purify the endogenous
yperphosphorylated form of Swe1, we used the GAL1
romoter to express 3×HA-Swe1 and a version of Clb2
acking the destruction box. This caused cells to arrest
n mitosis with 3×HA-Swe1 in the partially hyperphos-
horylated form (data not shown). The 3×HA-Swe1 was
urified by immunoaffinity chromatography in the pres-
nce of very high concentrations of phosphatase inhibi-
ors, which proved to be critical for preservation of the
hosphorylation state of Swe1. Mapping data revealed
hat the in vivo form of 3×HA-Swe1 isolated in this man-
er was phosphorylated on 16 of the 19 sites that were
hosphorylated by Clb2/Cdc28 in vitro (Table 1). Phos-
horylation of the additional three sites may have been
ost during purification. The mapped sites also included
of the 14 sites that were uniquely phosphorylated by
dc28-Y19F in vitro. Since our studies did not allow
uantitative determination of the phosphorylation stoi-
hiometry, these sites may be phosphorylated on a
mall fraction of the purified 3×HA-Swe1. One might
xpect these sites to be phosphorylated if Mih1 is
ctive in cells arrested in mitosis, which would lead to
ontinual cycles of phosphorylation and dephosphory-
ation of Cdc28 and consequent cycles of Swe1 hyper-
hosphorylation and dephosphorylation.
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411Table 1. Swe1 Phosphorylation-Site-Mapping Data
In Vitro In Vivo
Sequence of Identified Peptide Site Cdc28 Cdc28-Y19F Cdc28
QAGEDES*DDFAIGGST*PTNK S36, T45 (S44) − − +
QAGEDES*DDFAIGGST*PTNK T45 (S44) + + +
FYPYS*NNK S56 (Y55) + + −
FYPYS*NNKLT*R T61 − + −
S*TGTLNLS*LSNT*ALSEANSKa S63 (T64, T66) + + +
S*TGTLNLS*LSNT*ALSEANSKa S70 (S72, T74) − − +
S*TGTLNLS*LSNT*ALSEANSKa T74 (S72, S77) + + +
IEEEEEEEEEGKDEES*VDS*R S102 − + +
IEEEEEEEEEGKDEESVDS*R S105 (S102) + + +
WS*PFHENESVTT*PITK S111 + + +
WS*PFHENES*VTT*PITK S118 (T120) − − +
WS*PFHENESVTT*PITK T121 (T120) + + +
RWS*PFHENESVTT*PIT*KR T124 + + −
S*AEKTNS*PISLK S127 + − +
TNS*PIS*LKQWNQR S133 + + +
TNS*PIS*LKQWNQR S136 + + +
TENTSSSSSYSVAKPNQSAFTSSGLVSK 2 or 3 sites within S156–S160 + (2) − + (3)
and S162
MSMDTS*LY*PAK T184 (S185) − + +
IPET*PVKKS*PLVEGR T196 + + +
IPET*PVKKS*PLVEGR S201 + + +
HVHLS*SSK S215 (S216, S217) − + +
ALPS*IHVPTIDSS*PLS*EAK S254 − + −
ALPSIHVPTIDS*S*PLS*EAK S262 − − +
ALPS*IHVPTIDSS*PLS*EAKb S263 (S262) + + +
ALPS*IHVPTIDSS*PLS*EAKb S266 + + +
HNNQTNILS*PTNSLVTNSS*PQTLHSNK S284 − − +
HNNQTNILS*PTNSLVTNSS*PQTLHSNK S294 (S293) − − +
HNNQTNILS*PTNSLVTNSS*PQTLHSNK 2 sites within T286, S288, − − +
T291, and S293
ARNS*VILK S312 − + +
ELTNS*LQQFK S323 − + +
DDLYGTDENFPPPIIIS*SHHSTR S345 (S346, S349, T350) − − +
GRYDNDT*DEEIST*PTR T367 (Y363) + + +
GRYDNDT*DEEIST*PTR T373 (S372) + + +
RKS*IIGATSQTHR S379 − − +
SIIGAT*S*QTHRc T384 (S385, T387) + + −
SIIGAT*S*QTHR S385 (T387) − + −
ESRPLSLSSAIVTNTTSAETHSISSTDSSPLNSKR 3 sites within S413–T415, − − +
S417, and S418
LIS*S*NKLSANPDSHLFEK S428 (S433) − + −
LIS*S*NKLSANPDSHLFEK S429 (S433) − + −
FTNVHS*IGK S449 − + −
LGDFGMATHLPLEDKS*FENEGDR S610 − − +
LRS*GDLSDAGRd S664 (S668) − + +
LSST*DIHSESLFSDITKd T676 (S674, S675) − + +
LSSTDIHSESLFS*DITK S685 (S680, S682) − + −
VDT*NDLFDFER T692 − − +
Phosphorylation is indicated by an asterisk. The amino acids referred to in column 2 are underlined. When additional sites are listed in
parentheses, an unambiguous assignment of the phosphorylation site was not possible on the basis of the MS/MS data, although detailed
analysis of the data led to a preference for most of the sites given outside the parentheses.
a The triply phosphorylated peptide STGTLNLSLSNTALSEANSK was only detected for Swe1 protein phosphorylated in vivo, while singly and
doubly phosphorylated peptides were identified for the samples phosphorylated in vitro by Cdc28 and Cdc28-Y19F, respectively.
b Phosphorylation at S254 as indicated on these peptides was only detected for Swe1 phosphorylated by Cdc28-Y19F.
c Phosphorylation at both residues, T384 and S385, was only detected for Swe1 phosphorylated by Cdc28-Y19F; for Swe1 phosphorylated
by Cdc28, an unambiguous assignment of the phosphorylation site was not possible.
d The assignment was unambiguous for the in vitro phosphorylated sample. For the in vivo phosphorylated sample, the assignment was
based on the following phosphopeptide: S*GDLSDAGRLS*STDIHSESLFSDITK.The in vivo mapping experiments also identified 12
sites that were not phosphorylated in vitro by Clb2/
Cdc28. It is therefore likely that additional kinases
phosphorylate Swe1 in vivo. Four of these sites were
previously found to be phosphorylated by Cla4 or Cdc5
in vitro (S36, S118, S379, and S610) (Sakchaisri et al.,
2004).We first addressed the significance of phosphoryla-
tion of Swe1 by Clb2/Cdc28. To do this, we made a
mutant version of Swe1 in which 18 of the 19 sites
phosphorylated by Clb2/Cdc28 in vitro were converted
to alanines (swe1-18A). The serines at S156–S160 were
not mutated due to ambiguities in the mapping data.
The endogenous SWE1 gene was replaced with the
Cell
412Figure 3. Mapping of Clb2/Cdc28 Phosphorylation Sites on Swe1
(A) The distribution of Clb2/Cdc28 and Clb2/Cdc28-Y19F phosphorylation sites on Swe1.
(B) Identification of phosphorylation at the serine residue S133 of Swe1 using MS/MS. The upper panel shows the predicted fragmentation
scheme (b and y type ions) for the peptide ion T131-K138 produced by trypsin proteolysis of Swe1 phosphorylated by Cdc28. Phosphorylation
at S133 is indicated by an asterisk. The lower panel shows the acquired MS/MS spectra of the doubly charged peptide ion (m/z 470.3).
Predicted fragment ions observed in the MS/MS spectrum are underlined in the upper panel.
(C) The Swe1-18A mutant fails to undergo hyperphosphorylation in vivo. Wild-type and swe1-18A cells were arrested in G1 by addition of α
factor. After release from the arrest, samples were taken every 10 min at the indicated times.
(C–E) Western blot analysis of (C) Swe1, (D) Clb2, and (E) Cdc28 phosphotyrosine levels.
(F) The Swe1-8A mutant is phosphorylated in vivo. Western blots comparing Swe1 and Swe1-8A phosphorylation during the cell cycle.swe1-18A mutant. To test the effect of the mutations 3
ton Swe1 hyperphosphorylation, we released swe1-18A
and control cells from a G1 arrest and monitored Swe1- o
h18A hyperphosphorylation by Western blotting (FigureC). We also assayed levels of the cyclin Clb2 to moni-
or cell-cycle progression (Figure 3D). The results dem-
nstrated that Swe1-18A completely failed to undergo
yperphosphorylation as cells enter mitosis. Since vir-
Cdk1-Dependent Activation of Wee1
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the swe1-18A mutations, it appears that phosphoryla-
tion of these sites is required for further phosphoryla-
tion of the remaining 14 sites.
A mutant version of Swe1 in which only the eight Cdc28
consensus sites were mutated to alanines (swe1-8A)
still underwent partial hyperphosphorylation (Figure
3F), further suggesting that the nonconsensus sites are
relevant in vivo. Except where noted, we utilized the
swe1-18A allele for further experiments because it elimi-
nated Swe1 hyperphosphorylation more completely.
Failure to Hyperphosphorylate Swe1 Causes
Premature Entry into Mitosis
We next characterized the phenotype caused by swe1-
18A. Western blotting with a phosphospecific antibody
revealed that swe1-18A causes a dramatic reduction in
Cdc28 tyrosine 19 phosphorylation (Figure 3E). In addi-
tion, swe1-18A cells entered mitosis prematurely and
showed a small-cell phenotype similar to swe1 (Fig-
ures 4A and 4B). Note in Figure 3D that Clb2 levels
peaked and declined earlier in swe1-18A cells relative
to wild-type, providing further evidence for premature
entry into mitosis (Figure 3D). Overexpression of Swe1-
18A from the GAL1 promoter failed to arrest the cell
cycle at G2/M in the same way as wild-type Swe1 (Fig-
ure 4C). Taken together, these observations demon-
strate that swe1-18A behaves similarly to swe1.
Clb2/Cdc28 Stimulates the Kinase Activity of Swe1
One possible explanation for these results is that Swe1-
18A is not active as a Cdc28 tyrosine kinase. We there-
fore carried out in vitro kinase assays to compare the
ability of Swe1 and Swe1-18A to phosphorylate Clb2/
Cdc28. To ensure that the assays were carried out un-
der conditions where substrate is in excess, we added
two amounts of Swe1 to the assay. The assays demon-
strated that Swe1-18A has reduced kinase activity (Fig-
ure 4D). This was somewhat unexpected because none
of the mutations in swe1-18A is near the kinase domain
(Figure 3A). We therefore considered the possibility that
phosphorylation of Swe1 by Clb2/Cdc28 is required for
full activation of Swe1. To test this, we set up kinase
reactions containing Swe1 and Clb2/Cdc28-as or con-
trol reactions containing Swe1 and Clb2/Cdc28. We
then determined whether inhibition of Cdc28-as with
1NM-PP1 inhibited the ability of Swe1 to phosphorylate
Cdc28-as. In the control reactions, addition of 1NM-
PP1 had no effect upon phosphorylation of Cdc28 by
Swe1 or phosphorylation of Clb2 by Cdc28, as ex-
pected (Figure 4E). In contrast, 1NM-PP1 completely
inhibited phosphorylation of Clb2 by Cdc28-as and
strongly inhibited phosphorylation of Cdc28-as by
Swe1 (Figure 4E). Similar reactions were carried out
using Swe1-18A. In this case, we found that inhibiting
Cdc28-as had little effect on the low basal activity of
Swe1-18A, as expected if Cdc28-as is unable to phos-
phorylate and activate Swe1-18A (Figure 4E). We con-
clude that Swe1 has a low basal kinase activity toward
Cdc28 that is stimulated when Swe1 is partially hyper-
phosphorylated by Clb2/Cdc28.Phosphorylation of Swe1 by Cdc28 Is Required
for Formation of a Stable Complex
Swe1-18A caused a reduction in Cdc28 phosphoryla-
tion in vitro but a nearly complete loss of Cdc28 phos-
phorylation in vivo. Studies on the interaction between
Swe1 and Clb2/Cdc28 provide an explanation for this
difference. In coimmunoprecipitation assays, wild-type
Swe1 associated with Clb2/Cdc28 in crude cell extracts
(Figure 5A). However, Swe1-18A was completely unable
to form a complex with Clb2/Cdc28. In addition, note
that only the partially hyperphosphorylated form of wild-
type Swe1 associated with Clb2/Cdc28 (Figure 5A). A
model that could explain these observations is that par-
tial hyperphosphorylation of Swe1 by Cdc28 leads to
stimulation of Swe1 kinase activity and formation of a
stable Swe1-Clb2/Cdc28 complex that maintains Cdc28
in the tyrosine-phosphorylated state. In swe-18A cells,
the failure to phosphorylate Swe1 would result in failure
to efficiently phosphorylate Cdc28, failure to form a sta-
ble complex, dissociation of Clb2/Cdc28, and rapid de-
phosphorylation of Cdc28 by Mih1. We found that dele-
tion of the MIH1 gene significantly restored Cdc28
tyrosine phosphorylation in swe1-18A cells, which is
consistent with the model (Figure 5B). Interestingly,
however, the timing of Cdc28 tyrosine phosphorylation
was different in swe1-18A or swe1-18A mih1 cells. In
wild-type cells, tyrosine phosphorylation peaked before
Clb2 reached peak levels, as expected if tyrosine phos-
phorylation delays entry into mitosis. In swe1-18A or
swe1-18A mih1 cells, however, tyrosine phosphoryla-
tion of Cdc28 followed Clb2 levels. This would be ex-
pected if Swe1-18A is able to phosphorylate Cdc28 at
a low rate but is unable to form a stable complex with
Clb2/Cdc28 that protects Cdc28 from dephosphoryla-
tion prior to entry into mitosis. Note that Cdc28 ap-
peared to undergo dephosphorylation in the absence
of Mih1, which suggests that there is another phospha-
tase that can dephosphorylate Cdc28.
Interestingly, the unphosphorylated form of Swe1 and
Swe1-18A were able to form a complex with Clb2/
Cdc28 in vitro but not in vivo (Figure 2A and Figure S2).
This suggests that there is an activity in yeast cells that
inhibits the association of unphosphorylated Swe1 with
Clb2/Cdc28.
Taken together, these data suggest that partial hyper-
phosphorylation of Swe1 by Clb2/Cdc28 leads to acti-
vation of the inhibitory activity of Swe1 and formation
of a complex that maintains Clb2/Cdc28 in the tyrosine-
phosphorylated state.
The Fully Hyperphosphorylated Form of Swe1
Dissociates from Clb2/Cdc28
We next addressed the functional significance of full
hyperphosphorylation of Swe1 by Clb2/Cdc28-Y19F.
An important clue came from experiments in which we
tested for interactions between Swe1 and Clb2/Cdc28-
Y19F. In coimmunoprecipitation assays, Swe1 copre-
cipitated with wild-type Clb2/Cdc28 in crude extracts
but completely failed to coprecipitate with Clb2/Cdc28-
Y19F (Figure 6A). The same result was obtained when
we carried out the reciprocal experiment to determine
whether Clb2/Cdc28 or Clb2/Cdc28-Y19F coprecipi-
tated with Swe1 (data not shown). These results sug-
Cell
414Figure 4. Characterization of the swe1-18A Mutant
(A) Wild-type and swe1-18A cells were arrested in G1 by addition of α factor. After release from the arrest, samples were taken every 10 min,
and cells were stained with an anti-tubulin antibody. The percentage of cells with short spindles was determined and plotted as a function
of time.
(B) Representative size distributions of log-phase cultures of swe1, swe1-18A, and wild-type strains (median cell size: 40 fL for swe1 and
swe1-18A; 45 fL for wild-type).
Cdk1-Dependent Activation of Wee1
415in which the 14 sites uniquely phosphorylated by Cdc28- sis until a critical size has been reached (Fantes and
(C) Wild-type Swe1 and swe1-18A were expressed from the GAL1 promoter, and samples were collected every 30 min for 3 hr. Western blots
show the amount of Clb2 protein and tyrosine-phosphorylated Cdc28 present as a function of time after addition of galactose.
(D) Purified Clb2/Cdc28 was incubated with the indicated amounts of Swe1 or Swe1-18A in the presence of [γ-32P]ATP, and phosphorylation
events were assayed by autoradiography after SDS-PAGE.
(E) The indicated combinations of proteins were incubated in the presence or absence of 25 M 1NM-PP1 or a similar amount of DMSO, and
phosphorylation events were assayed by autoradiography after SDS-PAGE.Figure 5. Phosphorylation of Swe1 Is Re-
quired In Vivo for Stable Swe1-Clb2/Cdc28
Complex Formation
(A) 3×HA-Clb2 was expressed from the GAL1
promoter in wild-type and swe1-18A cells.
Extracts were made from rapidly growing
cells of each strain, and Clb2-3×HA was im-
munoprecipitated with an anti-HA antibody.
As a control, identical precipitations were
carried out using an anti-GST antibody. Co-
precipitation of Swe1 was assayed by West-
ern blotting. The panels labeled “Extract”
show Western blots of 3×HA-Clb2 and Swe1
in the crude extracts used for the immuno-
precipitations demonstrating that equal
amounts of each protein were present. Note
the reduced levels of Cdc28 phosphotyro-
sine in the swe1-18A extract.
(B) Wild-type, swe1-18A, and swe1-18A
mih1 cells were arrested in G1 by addition
of α factor. After release from the arrest,
samples were taken every 10 min at the indi-
cated times, and Western blotting was used
to assay levels of Clb2 and Cdc28 phospho-
tyrosine.gested that the fully hyperphosphorylated form of Swe1
dissociates from Clb2/Cdc28. This possibility was
tested with purified proteins. Clb2/Cdc28 or Clb2/
Cdc28-Y19F was bound to beads, and purified Swe1
was added to form complexes, as in the experiment
shown in Figure 2A. The complexes were then divided
into two aliquots, and ATP was added to one to induce
Swe1 hyperphosphorylation. Finally, the beads were
washed with buffer, and association of Swe1 was as-
sayed by Western blotting. This experiment revealed
that the fully hyperphosphorylated form of Swe1 disso-
ciates from Clb2/Cdc28-Y19F complexes in vitro, while
partially phosphorylated or unphosphorylated Swe1 re-
main associated (Figure 6B).
Taken together, these results suggest that dephos-
phorylation of Cdc28 triggers full hyperphosphorylation
of Swe1 and release of the Clb2/Cdc28 complex. To test
this idea in vivo, we generated a mutant version of Swe1Y19F were changed to alanines. This allele caused a
short delay in entry into mitosis; however, we found that
it still underwent nearly full hyperphosphorylation in
vivo and in vitro (data not shown). Examination of the
N-terminal 443 amino acids of Swe1 revealed that there
are 108 serines or threonines. It therefore appears that
there are numerous alternative phosphorylation sites
that can be used when the 14 sites normally phosphor-
ylated by Cdc28-Y19F are converted to alanines. Addi-
tional work will be necessary to define the function of
full hyperphosphorylation of Swe1.
Discussion
Wee1-related kinases are thought to delay entry into
mitosis until appropriate conditions have been met. In
both budding yeast and fission yeast, it has been pro-
posed that Wee1-related kinases delay entry into mito-
Cell
416Figure 6. Hyperphosphorylation of Swe1 Causes Dissociation of the Swe1-Clb2/Cdc28 Complex
(A) Coimmunoprecipitation experiments were carried out exactly as in Figure 6A, except that 3×HA-Clb2 was expressed from the GAL1
promoter in wild-type and cdc28-Y19F cells.
(B) Swe1 phosphorylation reactions were carried out exactly as in Figure 2A, except that, after the phosphorylation reaction, the anti-Clb2
beads were washed four times with buffer.
(C) A model summarizing the signaling interactions observed between Swe1 and Clb2/Cdc28.Nurse, 1977; Harvey and Kellogg, 2003; Kellogg, 2003; i
nNurse, 1975; Rupes, 2002). However, alternative mod-
els have been proposed, and it has been difficult to p
pprecisely define the physiological and molecular sig-
nals that impinge upon Wee1-related kinases to regu- C
tlate entry into mitosis (Lew, 2003). A full understanding
of these signals will require a detailed knowledge of the
pmechanisms that regulate Wee1-related kinases.
t
ARegulation of Swe1 by Clb2/Cdc28
The experiments described here provide new insights c
yinto the molecular mechanisms that regulate Swe1 and
entry into mitosis. A model summarizing our results is s
ashown in Figure 6B. We propose that Swe1 binds newly
made Clb2/Cdc28 complexes as they appear in late G2. t
vSequential reciprocal phosphorylation events between
Swe1 and Clb2/Cdc28 lead to partial hyperphosphory- A
blation of Swe1 and to phosphorylation and inhibition of
Cdc28. Partial hyperphosphorylation of Swe1 stimu- b
rlates the ability of Swe1 to phosphorylate Cdc28 and is
required in vivo for formation of a Swe1-Clb2/Cdc28 i
Wcomplex that maintains Clb2/Cdc28 in an inhibited
state. One function of Swe1 at this point may be to act t
Cas a buffer that binds and inactivates newly made Clb2/
Cdc28, thereby allowing generation of a large pool of tnactive Clb2/Cdc28 that can be rapidly and coordi-
ately activated to trigger entry into mitosis. Dephos-
horylation of Cdc28 by Mih1 allows full hyperphos-
horylation of Swe1 by Clb2/Cdc28 and release of the
lb2/Cdc28 complex. Cdc28 is therefore both a posi-
ive and negative regulator of Swe1.
It has been proposed that Xenopus Cdk1 directly
hosphorylates and inactivates Wee1 to create a posi-
ive feedback loop that helps trigger entry into mitosis.
number of observations support this model. Cdk1
an phosphorylate Wee1 in vitro, and a hyperphosphor-
lated form of Wee1 isolated from mitotic extracts
hows 7- to 20-fold reduced kinase activity (Mueller et
l., 1995; Tang et al., 1993). In addition, immunodeple-
ion of mitotic Cdk1 from Xenopus egg extracts pre-
ents Wee1 hyperphosphorylation (Mueller et al., 1995).
lthough attractive, this model has never been tested
y determining whether direct phosphorylation of Wee1
y Cdk1 leads to inhibition of Wee1. It has therefore
emained possible that the inhibition of Wee1 observed
n mitotic extracts is due to other factors that inhibit
ee1 kinase activity rather than to direct phosphoryla-
ion by Cdk1. In addition, it has remained unknown how
dk1 can phosphorylate Wee1, since Wee1 is an inhibi-
or of Cdk1.
Cdk1-Dependent Activation of Wee1
417Our work with budding-yeast Swe1 provides new
support for key aspects of this model. Clb2/Cdc28 di-
rectly phosphorylates Swe1, and full hyperphosphory-
lation of Swe1 triggers dissociation from Clb2/Cdc28,
which is likely to relieve inhibition of Cdc28 kinase ac-
tivity. Moreover, the ability of Clb2/Cdc28 to activate
Swe1 explains how Clb2/Cdc28 can phosphorylate its
own inhibitor. In contrast to the Xenopus model, how-
ever, it appears that Clb2/Cdc28 cannot act alone to
inactivate Swe1. Rather, dephosphorylation of Cdc28
appears to be a critical step that triggers full hyper-
phosphorylation of Swe1 and release of Clb2/Cdc28. It
therefore seems unlikely that there is a simple feedback
loop in which Clb2/Cdc28 works alone to inactivate
Swe1.
Previous work reached the conclusion that binding of
Swe1 contributes to inhibition of Cdc28 independently
of Cdc28 tyrosine phosphorylation (McMillan et al.,
1999b). In these experiments, a putative inactive form
of Swe1 was generated by mutating a conserved ly-
sine in the kinase domain to a proline (Swe1-K473P).
Overexpression of Swe1-K473P caused a prolonged
mitotic delay; however, we made a similar allele of
Swe1 and found that it retained kinase activity (Figure
S1). Work on another kinase independently reached the
conclusion that the conserved lysine mutated in the
swe1-K473P mutant is not always required for catalytic
activity (Xu et al., 2000). Overexpression of a true cata-
lytically inactive Swe1 (Swe1-N584A) does not cause a
prolonged mitotic delay (Figure S1 and S.L.H. and D.R.K.,
unpublished data). We conclude that Swe1 binding
alone does not make a significant contribution to inhibi-
tion of Cdc28. Rather, binding of Swe1 is necessary to
maintain Cdc28 in the phosphorylated and inhibited
state in vivo.
It has also been proposed that proteolytic destruc-
tion of Swe1 is the key event that inactivates Swe1 and
allows entry into mitosis (McMillan et al., 1998, 1999a;
Sia et al., 1998). This model is based on the observation
that Swe1 is stabilized in cells undergoing Swe1-depen-
dent checkpoint arrests. However, it is not yet possible
to distinguish whether stabilization of Swe1 is a cause
or consequence of checkpoint arrests. To determine
the relative importance of Swe1 destruction for entry
into mitosis, it will be necessary to map and mutate the
sequences in Swe1 that target it for destruction. If
Swe1 destruction is necessary for entry into mitosis,
one would predict that these mutations should stabilize
Swe1 and prevent mitotic entry.
A surprising result from this study is that Clb2/Cdc28
is able to phosphorylate numerous sites on Swe1 that
do not conform to the previously determined core con-
sensus site for cyclin-dependent kinases (S/TP). Bind-
ing of Clb2/Cdc28 to Swe1 may create a locally high
concentration of Cdc28 that drives phosphorylation of
kinetically unfavorable sites. Previous work indepen-
dently found that binding interactions can drive phos-
phorylation of suboptimal sites by Cdk2 (Takeda et al.,
2001).
Mechanisms that Trigger Entry into Mitosis
The discovery that a Swe1-Clb2/Cdc28 complex repre-
sents the inhibited form of Cdc28 brings a new focusto efforts to understand the mechanisms that control
entry into mitosis. Resolution of this complex is likely
to represent a critical step in the series of events that
lead to mitotic entry. Perhaps the most simple model
for entry into mitosis is that activation of Mih1 results
in dephosphorylation of Cdc28, hyperphosphorylation
of Swe1, and release of active Clb2/Cdc28. In this
model, the critical decision to enter mitosis would be
made by regulating Mih1. Interestingly, recent work in
fission yeast has suggested that coordination of cell
growth and cell division at G2/M may work primarily
through regulation of Cdc25, the fission-yeast Mih1 ho-
molog (Rupes et al., 2001). In addition, work in Dro-
sophila and fission yeast has shown that Cdc25 activity
can be limiting for entry into mitosis (Edgar and O’Far-
rell, 1989, 1990; Rupes et al., 2001; Russell and Nurse,
1986). However, we suspect that entry into mitosis will
be more complex and will require intricate regulation of
both Swe1 and Mih1. The finding that inhibition of
Cdc28 causes rapid loss of Swe1 hyperphosphoryla-
tion in vivo demonstrates that there is a highly active
phosphatase that acts on Swe1. One might imagine
that this phosphatase acts continuously on Swe1 to
counteract the activity of Cdc28, thereby causing Swe1
to undergo continuous rounds of phosphorylation and
dephosphorylation. In this case, the phosphorylation
state of Swe1 would depend on the relative activities
of Cdc28 and the phosphatase, and inhibition of the
phosphatase would be required for hyperphosphoryla-
tion of Swe1 and resolution of the Clb2/Cdc28 com-
plex. This kind of highly dynamic signaling could allow
the cell to continuously monitor conditions while mak-
ing the decision to enter mitosis.
It is also likely that there are additional kinases that
regulate Swe1. Work in Xenopus and fission yeast has
shown that members of the Nim1 kinase family can
phosphorylate Wee1 and may negatively regulate its ki-
nase activity, although the in vivo relevance of phos-
phorylation by these kinases has not yet been clearly
defined (Breeding et al., 1998; Coleman et al., 1993;
Kanoh and Russell, 1998; Young and Fantes, 1987). Our
phosphorylation-site-mapping experiments also iden-
tified 12 sites that are phosphorylated in vivo but are
not phosphorylated by Clb2/Cdc28 in vitro. Phosphory-
lation of these sites is likely to be due to the activities
of additional kinases. Four of these sites are among the
sites that were previously found to be phosphorylated
by Cla4 or Cdc5 in vitro. Mutation of all of the sites
phosphorylated by Cla4 and Cdc5 in vitro causes no
phenotype in a wild-type background and a mild en-
hancement of the elongated-cell phenotype observed
in mih1 cells (Sakchaisri et al., 2004).
In budding yeast, an intricate signaling network plays
a critical role in regulation of Swe1 hyperphosphoryla-
tion (Kellogg, 2003). This network includes the kinases
Gin4, Hsl1, Cla4, and Elm1 as well as a number of pro-
teins required for regulation of these kinases, including
Nap1, Hsl7, and the septins. Inactivation of this signal-
ing network results in a failure to fully hyperphosphory-
late Swe1 and a prolonged G2/M delay (Shulewitz et
al., 1999; Sreenivasan and Kellogg, 1999). These results
suggest that inactivation of the signaling network may
result in a failure to resolve the Swe1-Clb2/Cdc28 com-
plex. The molecular mechanisms by which the network
Cell
418Sinfluences Swe1 hyperphosphorylation are largely un-
Cknown, as are the physiological signals that feed into
pthe signaling network. Considerable additional work
p
will be necessary to fully understand the molecular d
mechanisms and physiological signals that regulate m
DWee1-related kinases and entry into mitosis.
cExperimental Procedures
t
2Yeast Strains, Plasmids, and Culture Conditions
aThe strains, plasmids, and culture conditions used for these
astudies are listed in the Supplemental Data. Mutant versions of
MSWE1 were synthesized by DNA 2.0 (Menlo Park, California) and
Dwere integrated at the SWE1 locus to replace the endogenous
scopy.
f
ECell-Size Analysis
wCell-size analysis was carried out as previously described (Jorgen-
gsen et al., 2002), except that cultures were grown overnight at 30°C
cin YPD to OD600 0.6 and 150 l of culture was diluted into 20 ml
aIsoton II. The median cell size reported is the average of three inde-
wpendent experiments.
m
aEffects of Cdc28-as Inhibition on Swe1 Phosphorylation
aCells carrying the cdc28-as allele (SH15) or wild-type control cells
m(DK247) were arrested in mitosis by expression of a nondegradable
vversion of Clb2 (pAR39) as previously described (Rudner et al.,
2000; Tjandra et al., 1998). A 1.6 ml sample was removed to be
lmock treated with DMSO, and 25 M 1NM-PP1 was added to the
Cremaining cells. Samples were collected at 1, 2.5, and 5 min after
waddition of 1NM-PP1. The mock-treated sample was collected after
b5 min. Swe1 hyperphosphorylation was assayed by Western blot-
fting as previously described (Harvey and Kellogg, 2003).
tTo determine the effects of inhibiting Cdc28 during a normal cell
dcycle, cdc28-as cells (JAU05) were arrested in G1 using α factor.
mThe culture was released from the arrest into fresh YPD media at
h30°C, and a 1.6 ml sample was removed at 90 min to be mock
itreated with DMSO. Twenty-five micromolar 1NM-PP1 was added
sto the remaining cells, and 1.6 ml samples were collected at 1,
y2.5, 5, and 10 min. The mock-treated sample was collected after
10 min.
SImmunoaffinity Purifications and Kinase Assays
SImmunoaffinity purifications of Clb2-3×HA/Cdc28, Clb2-3×HA/
cCdc28-as, 3×HA-Swe1, 3×HA-Swe1-18A, and 3×HA-Swe1-8A were
acarried out in the presence of 1M KCl using the same protocol used
Dpreviously to purify Gin4, with some modifications (Mortensen et
al., 2002). Kinase assays were carried out by mixing purified pro-
teins together in the presence of ATP. In some cases, kinase assays A
were carried out with purified Clb2/Cdc28 complexes bound to
beads with anti-Clb2 antibodies. Detailed methods for purification W
of proteins and kinase assays are provided in the Supplemental A
Data. m
M
aCoimmunoprecipitation of Clb2-3×HA/Cdc28 and Swe1
wAssociation of Clb2/Cdc28 and Swe1 in crude extracts was as-
psayed as previously described for Gin4 and Nap1, with some ex-
Gceptions (Mortensen et al., 2002). To test whether fully hyperphos-
phorylated Swe1 dissociates from Clb2-3×HA/Cdc28-Y19F in vitro,
we formed complexes between Swe1 and Clb2/Cdc28-Y19F or Clb2/
RCdc28 on beads. The beads were then divided into two aliquots,
Rand ATP was added to one, followed by incubation at 30°C. The
Abeads were washed with buffer, and Swe1 protein remaining bound
Pto the beads was assayed by Western blotting. A detailed descrip-
tion of the methods used to assay association between Swe1 and
RClb2/Cdc28 is provided in the Supplemental Data.
BPhosphorylation-Site Mapping by Tandem Mass Spectrometry
(In order to map in vitro phosphorylation sites on Swe1, we scaled
Mup the reactions in Figure 2A. The hyperphosphorylated Swe1 pro-
tein bands and an unphosphorylated control band were excised B
Bfrom the gel. For mapping of in vivo phosphorylation sites, 3×HA-we1 was purified from cells expressing a nondegradable form of
lb2 that arrests cells in mitosis. Purification was carried out in the
resence of a buffer that contained very high concentrations of
hosphatase inhibitors to prevent dephosphorylation of Swe1. A
etailed description of the methods used to prepare proteins for
apping of phosphorylation sites is provided in the Supplemental
ata.
Mapping of phosphorylation sites on Swe1 was done by nanos-
ale reversed-phase liquid chromatography-tandem mass spec-
rometry (LC-MS/MS) as described previously (Peng and Gygi,
001). Protein from a colloidal Coomassie-stained SDS-polyacryl-
mide gel band was in-gel digested with trypsin (Shevchenko et
l., 1996), and the resulting peptide mixture was analyzed by LC-
S/MS using a fused silica microcapillary C18 column and an LCQ-
eca ion-trap mass spectrometer for the in vitro phosphorylation
ites or an LTQ FT hybrid linear ion-trap/FTICR mass spectrometer
or identification of the in vivo phosphorylation sites (Thermo
lectron). MS/MS data were acquired in an automated fashion and
ere searched against the Swe1 sequence using the SEQUEST al-
orithm (Eng et al., 1994) with no enzyme-specificity restriction and
onsidering the possibility of phosphorylation on serine, threonine,
nd tyrosine residues. Matches for tryptic phosphorylated peptides
ere validated manually with special consideration of intense frag-
ent ions formed through cleavage N-terminal to proline residues
nd neutral losses of phosphoric acid (Ballif et al., 2004). When
nalysis was done with the LTQ FT, only peptide matches with a
aximum mass deviation of 10 ppm were considered for further
alidation.
A single phosphorylation site was detected on the unphosphory-
ated form of Swe1 (T196) that was used as a substrate for Clb2/
dc28 and Clb2/Cdc28-Y19F. Since this is a Cdc28 consensus site,
e think that it is likely that this site was already phosphorylated
y Cdc28 in vivo. The buffer that we used to purify the 3×HA-Swe1
or the in vitro mapping experiments did not fully inhibit phospha-
ases, and significant dephosphorylation of 3×HA-Swe1 occurred
uring purification. It is likely that we would have identified even
ore sites on the “unphosphorylated” form of 3×HA-Swe1 if we
ad purified it from cells in the presence of a buffer that fully inhib-
ted dephosphorylation. For mapping of in vivo phosphorylation
ites, we used a buffer that more completely inhibited dephosphor-
lation of Swe1.
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